These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29363994)

  • 1. Improving combination cancer therapy: the CombiPlex
    Tolcher AW; Mayer LD
    Future Oncol; 2018 Jun; 14(13):1317-1332. PubMed ID: 29363994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo.
    Dicko A; Mayer LD; Tardi PG
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1329-41. PubMed ID: 21118030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased preclinical efficacy of irinotecan and floxuridine coencapsulated inside liposomes is associated with tumor delivery of synergistic drug ratios.
    Harasym TO; Tardi PG; Harasym NL; Harvie P; Johnstone SA; Mayer LD
    Oncol Res; 2007; 16(8):361-74. PubMed ID: 17913044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties.
    Mayer LD; Tardi P; Louie AC
    Int J Nanomedicine; 2019; 14():3819-3830. PubMed ID: 31213803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice.
    Mayer LD; Harasym TO; Tardi PG; Harasym NL; Shew CR; Johnstone SA; Ramsay EC; Bally MB; Janoff AS
    Mol Cancer Ther; 2006 Jul; 5(7):1854-63. PubMed ID: 16891472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug ratio-dependent antagonism: a new category of multidrug resistance and strategies for its circumvention.
    Harasym TO; Liboiron BD; Mayer LD
    Methods Mol Biol; 2010; 596():291-323. PubMed ID: 19949929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes Co- encapsulating Anticancer Drugs in Synergistic Ratios as an Approach to Promote Increased Efficacy and Greater Safety.
    Franco MS; Oliveira MC
    Anticancer Agents Med Chem; 2019; 19(1):17-28. PubMed ID: 29692263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.
    Kim HP; Gerhard B; Harasym TO; Mayer LD; Hogge DE
    Exp Hematol; 2011 Jul; 39(7):741-50. PubMed ID: 21530609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing combination chemotherapy by controlling drug ratios.
    Mayer LD; Janoff AS
    Mol Interv; 2007 Aug; 7(4):216-23. PubMed ID: 17827442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer.
    Hu CM; Zhang L
    Biochem Pharmacol; 2012 Apr; 83(8):1104-11. PubMed ID: 22285912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ratiometric drug delivery using non-liposomal nanocarriers as an approach to increase efficacy and safety of combination chemotherapy.
    Franco MS; Oliveira MC
    Biomed Pharmacother; 2017 Dec; 96():584-595. PubMed ID: 29035823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronomic chemotherapy and nanocarrier platforms.
    Abu Lila AS; Ishida T
    Cancer Lett; 2017 Aug; 400():232-242. PubMed ID: 27838415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.
    Webb MS; Johnstone S; Morris TJ; Kennedy A; Gallagher R; Harasym N; Harasym T; Shew CR; Tardi P; Dragowska WH; Mayer LD; Bally MB
    Eur J Pharm Biopharm; 2007 Mar; 65(3):289-99. PubMed ID: 17123800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal cancer therapy: exploiting tumor characteristics.
    Kaasgaard T; Andresen TL
    Expert Opin Drug Deliv; 2010 Feb; 7(2):225-43. PubMed ID: 20095944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
    Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
    Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?
    Abu Lila AS; Okada T; Doi Y; Ichihara M; Ishida T; Kiwada H
    Int J Pharm; 2012 Apr; 426(1-2):263-270. PubMed ID: 22310465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antitumor effects of doxorubicin-loaded carboxymethyl cellulose nanoparticle in combination with endostar for effective treatment of non-small-cell lung cancer.
    Li M; Tang Z; Lin J; Zhang Y; Lv S; Song W; Huang Y; Chen X
    Adv Healthc Mater; 2014 Nov; 3(11):1877-88. PubMed ID: 24846434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinations.
    Ramsay EC; Dos Santos N; Dragowska WH; Laskin JJ; Bally MB
    Curr Drug Deliv; 2005 Oct; 2(4):341-51. PubMed ID: 16305437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment.
    Wong MY; Chiu GN
    Anticancer Drugs; 2010 Apr; 21(4):401-10. PubMed ID: 20110806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-based nanoparticulate systems for the delivery of anti-cancer drug cocktails: Implications on pharmacokinetics and drug toxicities.
    Chiu GN; Wong MY; Ling LU; Shaikh IM; Tan KB; Chaudhury A; Tan BJ
    Curr Drug Metab; 2009 Oct; 10(8):861-74. PubMed ID: 20214582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.